MedScan 3D wins MedTech Innovation Expo pitch competition, founder signals openness to investment

MedScan 3D, a UK-based startup founded by Jacqui O’Connor and James Wall, won the startup pitch competition at MedTech Innovation Expo 2026 in July. The company produces patient-specific 3D-printed anatomical vascular models derived from CT and MRI scan data, designed to help surgeons pre-plan complex procedures such as intracranial aneurysm repairs. O’Connor, who conceived the idea while working as a surgical rep, told TCT Magazine that while the company is currently self-funded, she would consider external investment if the right opportunity arose.

MedScan 3D operates at the intersection of medical-dental AM and software-service, specifically within the surgical planning and training segment. Its value proposition directly addresses a well-documented gap: the difficulty surgeons face interpreting 2D scans for spatially complex anatomy. The company competes with established medical modeling bureaus like Materialise and 3D Systems’ Healthcare division, but differentiates through a focus on vascular pathology and a founder-led clinical perspective. The pitch competition win provides validation and visibility, but the company remains at an early stage, with no disclosed revenue, production volume, or clinical validation studies. The openness to investment signals a potential shift from bootstrapped operations toward scaling, but the lack of a specific round or lead investor keeps this in the realm of intent rather than action.

For MedScan 3D, the practical next step is converting pitch-deck interest into a defined funding round with a clear use of capital-likely for regulatory clearance, clinical evidence generation, and sales capacity. The medical AM modeling market is growing but remains fragmented, and winning a pitch competition does not guarantee commercial traction. The company must now demonstrate repeatable case outcomes and hospital adoption to move from promising concept to credible supplier.